CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

L1000 LINCS DCIC 2021 ABY001 NCIH2073 24h CETUXIMAB 1.88uM (Biosample)

Subject:

NCIH2073

Subject (Entity type)
Sample Prep Method:

maintaining cell culture

Sample Prep Method (Entity type)
Project:

LINCS-2021

Project (Entity type)
Disease:

lung cancer

Disease (Entity type)
Dcc Asset:

datapackage.zip

Processed File (Entity type)
Dcc:

LINCS

DCC (Entity type)
Biosample:

L1000 LINCS DCIC ABY001 NCIH2073 24h CETUXIMAB 1.88uM.tsv.gz

File (Entity type)
Anatomy:

lung

Anatomy (Entity type)
Results found

Linked to

 

Label

Description

 

File

L1000 LINCS DCIC ABY001 NCIH2073 24h CETUXIMAB 1.88uM.tsv.gz

File (Entity type)

A 295 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

  • File

    L1000 LINCS DCIC ABY001 NCIH2073 24h CETUXIMAB 1.88uM.tsv.gz

    File (Entity type)

    A 295 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.